Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,041 DKK | +0.74% | +1.90% | -5.29% |
May. 15 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
May. 15 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
Sales 2024 * | 19.8B 2.88B | Sales 2025 * | 23.62B 3.44B | Capitalization | 132B 19.21B |
---|---|---|---|---|---|
Net income 2024 * | 4.68B 682M | Net income 2025 * | 6.63B 966M | EV / Sales 2024 * | 5.33 x |
Net cash position 2024 * | 26.36B 3.84B | Net cash position 2025 * | 33.63B 4.9B | EV / Sales 2025 * | 4.16 x |
P/E ratio 2024 * |
29.9
x | P/E ratio 2025 * |
21.5
x | Employees | 2,286 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.5% |
Latest transcript on Genmab A/S
1 day | +0.74% | ||
1 week | +1.90% | ||
Current month | +4.32% | ||
1 month | +2.33% | ||
3 months | +2.61% | ||
6 months | -7.94% | ||
Current year | -5.29% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 98-12-31 | |
Anthony Pagano
DFI | Director of Finance/CFO | 46 | 06-12-31 |
Anthony Mancini
COO | Chief Operating Officer | 53 | 20-03-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Deirdre Connelly
CHM | Chairman | 63 | 16-12-31 |
Director/Board Member | 73 | 03-10-31 | |
Rolf K. Hoffmann
BRD | Director/Board Member | 64 | 15-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.64% | 200 M€ | +17.40% | ||
1.28% | 48 M€ | +9.95% | ||
1.01% | 85 M€ | +1.65% | ||
0.75% | 17 M€ | +7.73% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 2,041 | +0.74% | 71,028 |
24-05-16 | 2,026 | -1.89% | 147,504 |
24-05-15 | 2,065 | +1.98% | 81,575 |
24-05-14 | 2,025 | +1.76% | 161,448 |
Delayed Quote Nasdaq Copenhagen, May 17, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.29% | 19.21B | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B | |
-24.95% | 8.23B |
- Stock Market
- Equities
- GMAB Stock